PAP Therapy Sleep Apnea and Exercise

NCT01786291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2013-02-07

No results posted yet for this study

Summary

Positive airway pressure (PAP) therapy is generally offered to patients with obstructive sleep apnea. The investigators suggest that beneficial effects of PAP therapy is by preventing apneas and therefore reducing cardiac and pulmonary morbidities. The investigators sought to verify this by assessing cardiac and pulmonary function during exercise.

Conditions

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Meral Uyar, Assoc Prof · University of Gaziantep

  • Nazan Bayram, Assis Prof · University of Gaziantep

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786291 on ClinicalTrials.gov